IQVIA Holdings Inc. Common Stock vs Norwegian Cruise Line Holdings Ltd — how do they compare? IQVIA Holdings Inc. Common Stock trades at $261.7 (market cap $42.61B), while Norwegian Cruise Line Holdings Ltd trades at $15.5 (market cap $7.11B). The key difference: IQVIA Holdings Inc. Common Stock is far larger — about 6× Norwegian Cruise Line Holdings Ltd's market cap, and IQVIA Holdings Inc. Common Stock is trading nearer its 52-week high, Norwegian Cruise Line Holdings Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold IQVIA Holdings Inc. Common Stock for 1 Days and Norwegian Cruise Line Holdings Ltd for 68 Days on average.
| IQV | NCLH | |
|---|---|---|
Market Cap | $42.61B | $7.11B |
Volume | 988,398 | 22,683,268 |
Sector | Health | Consumer Cyclical |
52-Week High | $275.02 | $25.02 |
52-Week Low | $156.66 | $14.12 |
Typical Hold Time | 1 Days | 68 Days |
Enterprise Value | $56.77B | $21.93B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NCLH trades at $15.495, up 2.96% today, with a bullish technical signal and strong recent earnings beats. The company reported Q2 2026 EPS of $0.48, exceeding expectations, and anticipates Q3 2026 results above guidance. Valuation metrics appear attractive with a P/E of 9.39 and P/S of 0.75. Analyst consensus is a Buy with a $20.86 price target, indicating 34% upside potential. Recent news highlights strategic initiatives like earlier booking resets and new senior note offerings to manage debt.
The outlook for NCLH is positive, driven by earnings momentum and favorable analyst sentiment, but risks include persistent yield pressure and high debt levels. Investment opportunity lies in the stock's discounted valuation relative to growth prospects, though investors must monitor Caribbean pricing trends and the company's ability to sustain profitability amid macroeconomic uncertainties.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
IQVIA provides clinical research, healthcare data, technology, and consulting services to life sciences companies. Its work supports drug development and commercialization.
Read more on IQV →Norwegian Cruise Line is the world's third-largest cruise company by berths (at more than 62,000), operating 29 ships across three brands (Norwegian, Oceania, and Regent Seven Seas), offering both freestyle and luxury cruising. The company has redeployed its entire fleet as of May 2022. With eight passenger vessels on order among its brands through 2027 (representing 20,000 incremental berths), Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sailed to around 500 global destinations before the pandemic.
Read more on NCLH →